An Open-Label Phase 1 Study to Examine the Effect of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770 in Healthy Subjects.

Trial Profile

An Open-Label Phase 1 Study to Examine the Effect of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Apr 2010

At a glance

  • Drugs Fluconazole; Ivacaftor; Midazolam; Rosiglitazone
  • Indications Anxiety disorders; Seizures; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Most Recent Events

    • 18 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Apr 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
    • 12 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top